News

Investors with an interest in Schools stocks have likely encountered both American Public Education (APEI) and Lincoln Educational Services Corporation (LINC). But which of these two companies is

Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for

Investors interested in stocks from the Automotive - Original Equipment sector have probably already heard of Strattec Security (STRT) and Atmus Filtration Technologies (ATMU). But which of these

Investors interested in stocks from the Banks - Foreign sector have probably already heard of Toronto-Dominion Bank (TD) and DBS Group Holdings Ltd (DBSDY). But which of these two stocks offers

Investors with an interest in Mining - Miscellaneous stocks have likely encountered both Nexa Resources S.A. (NEXA) and Teck Resources Ltd (TECK). But which of these two stocks offers value

Investors with an interest in Electronics - Miscellaneous Components stocks have likely encountered both TDK Corp. (TTDKY) and OSI Systems (OSIS). But which of these two stocks offers value

Investors looking for stocks in the Electronics - Miscellaneous Products sector might want to consider either Daktronics (DAKT) or Garmin (GRMN). But which of these two stocks is more attractive to

ManpowerGroup MAN reported impressive fourth-quarter 2025 results, beating the Zacks Consensus Estimate for both earnings and revenues.

The stock has gained 9.1% since the release of results on Jan

“Economists exist to make weathermen look good.”

Inflation: Why the Economists were Wrong

In early June 2021, then-Treasury Secretary Janet Yellen used the word ‘transitory’ to describe U.S.

CME Group Inc. CME is expected to register a decline in its top and bottom lines when it reports fourth-quarter 2025 results on Feb. 4, before the opening bell.The Zacks Consensus Estimate for CME’s

Alphabet GOOGL is set to report fourth-quarter 2025 results on Feb. 4. For fourth-quarter 2025, the Zacks Consensus Estimate for earnings is pegged at $2.58 per share, down by a penny over the past

The U.S. markets began 2026 with a decent performance. Some of the lingering concerns, including subdued labor markets, persistent inflation, geopolitical tension and tariff and trade policy

Investors in Canadian Natural Resources Limited CNQ need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 20, 2026 $45 Put had some of the

Tyson Foods, Inc. TSN reported solid first-quarter fiscal 2026 results, wherein the top line beat the Zacks Consensus Estimate and showed year-over-year growth, while the bottom line missed the same

Investors in Elevance Health, Inc. ELV need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 20, 2026 $460 Put had some of the highest implied

T. Rowe Price Group, Inc. TROW is scheduled to report fourth-quarter 2025 results on Feb. 04, 2026, before the opening bell. The company’s quarterly earnings and revenues are expected to have

Pre-market futures are trading in the red at this hour, but well up from the early-morning troughs between -1% and the Nasdaq and Russell 2000 -1.75%. Currently, the Dow is down a mere -0.12%, the

The Walt Disney Company DIS reported first-quarter fiscal 2026 adjusted earnings of $1.63 per share, which decreased 7% year over year. The figure beat the Zacks Consensus Estimate by 3.8%.Revenues

Gold and silver posted their steepest declines in years, reversing sharply after a powerful rally that had pushed prices to record levels. Gold prices, which have added about 66.08% over the past

Ultragenyx Pharmaceutical RARE announced the resubmission of its biologics license application (“BLA”) to the FDA seeking accelerated approval for AAV gene therapy candidate UX111, which is being

Lightspeed Commerce LSPD is scheduled to release its third-quarter fiscal 2026 results on Feb. 5.The Zacks Consensus Estimate for fiscal third-quarter earnings is pegged at 12 cents per share

Oshkosh Corporation OSK, which designs, develops, and manufactures custom-built vehicles and equipment, sent mixed signals to investors, with earnings declining year over year even as revenues

AstraZeneca AZN announced that it has entered into a new strategic collaboration with China-based CSPC Pharmaceutical to develop several next-generation therapies for obesity and type 2 diabetes

Coty Inc. COTY is likely to register a decline in the top line when it reports second-quarter fiscal 2026 earnings on Feb. 5. The Zacks Consensus Estimate for revenues is pegged at $1.66 billion